AMED Financial Facts
Interest income: 14KMiscellaneous, net: 1.71M
See Full Income Statement
Goodwill: 284.55M
Noncontrolling interests: 931K
See Full Balance Sheet
Amedisys (AMED) Earnings
|
Expand Research on AMED
Next EPS Date | 5/1/24 | EPS Growth Rate | +1.0% |
---|---|---|---|
Average EPS % Beat Rate | +5.0% | Revenue Growth Rate | +1.6% |
Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/8/14 | Q114 | -$0.07 | -$0.04 | -$0.03 | $298.74M | $301.89M | N/A | Details | |||
3/12/14 | Q413 | -$0.05 | -$0.01 | -$0.04 | $303.5M | $295.02M | N/A | Details | |||
2/28/13 | Q412 | N/A | $0.22 | N/A | N/A | $373.3M | = | N/A | N/A | ||
2/28/17 | Q416 | N/A | $0.39 | N/A | N/A | $369.43M | N/A | N/A | N/A | ||
5/1/24 | Q124 | N/A | $1.01 | N/A | N/A | $565.42M | N/A | N/A | N/A | ||
10/31/23 | Q323 | N/A | $1.08 | N/A | N/A | $560.59M | = | N/A | N/A | ||
11/2/21 | Q321 | $0.00 | $1.37 | -$1.37 | N/A | $568.37M | = | Details | |||
11/12/13 | Q313 | $0.06 | $0.13 | -$0.07 | $301.64M | $314.3M | = | Details |